Binding of Vascular Anticoagulant Alpha (VAC Alpha) to Planar Phospholipid Bilayers
Overview
Affiliations
Vascular anticoagulant alpha (VAC alpha, annexin V) is a member of the family of calcium and phospholipid binding proteins, the annexins. The binding properties of VAC alpha to phospholipid bilayers were studied by ellipsometry. Adsorption was calcium-dependent and completely reversible upon calcium depletion. Half-maximal adsorptions to phospholipid bilayers consisting of 100, 20, 5, and 1% dioleoyl-phosphatidylserine (DOPS) supplemented with dioleoyl-phosphatidylcholine (DOPC) were reached at Ca2+ concentrations of 0.04, 0.22, 1.5, and 8.6 mM. These surfaces all showed the same maximal adsorption of 0.22 +/- 0.01 micrograms of VAC alpha/cm2 (mean +/- S.D.). The adsorption to bilayers containing more than 10% DOPS was independent of VAC alpha concentrations in the range of 0.5-100 nM. Dissociation constants for VAC alpha binding to these surfaces were estimated to be below 2 x 10(-10) M. No adsorption was observed on pure DOPC bilayers at a Ca2+ concentration of 3 mM. The ability to mediate VAC alpha binding to 20% DOPS/80% DOPC bilayers was highly specific for Ca2+. The use of other divalent cations resulted in decreased binding in the order Cd2+ greater than Zn2+ greater than Mn2+ greater than Co2+ greater than Ba2+ greater than Mg2+. Zinc ions had a synergistic effect on Ca2(+)-dependent VAC alpha binding. The Ca2+ concentration needed for half-maximal binding to cardiolipin, dioleoyl-phosphatidylglycerol, DOPS, phosphatidylinositol, phosphatidic acid, dioleoyl-phosphatidylethanolamine, and sphingomyelin increased in that order. Adsorption was independent of the overall surface charge of the phospholipid membrane.
Nguyen H, Van K, Pham-The H, Le Q, Le-Nhat-Thuy G, Dang Thi T RSC Adv. 2025; 15(4):2825-2839.
PMID: 39877702 PMC: 11774189. DOI: 10.1039/d4ra08691k.
Caputo M, Ivanova D, Chasserot-Golaz S, Doussau F, Haeberle A, Royer C J Neurosci. 2024; 44(27).
PMID: 38839301 PMC: 11223464. DOI: 10.1523/JNEUROSCI.0042-24.2024.
ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma.
Wang W, Liu D, Yao J, Yuan Z, Yan L, Cao B Med Sci Monit. 2024; 30:e943523.
PMID: 38824386 PMC: 11155417. DOI: 10.12659/MSM.943523.
The Relevance, Predictability, and Utility of Annexin A5 for Human Physiopathology.
Jing J Int J Mol Sci. 2024; 25(5).
PMID: 38474114 PMC: 10932194. DOI: 10.3390/ijms25052865.
Sedenkova K, Leschukov D, Grishin Y, Zefirov N, Gracheva Y, Skvortsov D Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895970 PMC: 10610134. DOI: 10.3390/ph16101499.